Long-term treatment of uterine fibroids with ulipristal acetate

Fertility and Sterility

Volumn 101, Issue 6, 2014, Pages

  Donnez, Jacques ^a   Vázquez, Francisco ^b   Tomaszewski, Janusz ^c   Nouri, Kazem ^d   Bouchard, Philippe ^e   Fauser, Bart C J M ^f   Barlow, David H ^g   Palacios, Santiago ^h   Donnez, Olivier ⁱ   Bestel, Elke ^j   Osterloh, Ian ^k   Loumaye, Ernest ^l  

^a Society for Research Into Infertility SRI   (Belgium)

^b Centro de Estudios de Obstetricia Y Ginecología Asociado   (Spain)

^c Prywatna Klinika Polozniczo Ginekologiczna   (Poland)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

^e HÔPITAL SAINT ANTOINE   (France)

^f UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^g UNIVERSITY OF GLASGOW   (United Kingdom)

^h Palacios Institute of Women's Health   (Spain)

ⁱ UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^j PregLem   (Switzerland)

^k OsterMed   (United Kingdom)

^l Senior Dir NCD and Phase Rfis1   (Switzerland)

more..

Author keywords

Long term treatment; ulipristal acetate; uterine fibroid

Indexed keywords

NORETHISTERONE ACETATE; PLACEBO; ULIPRISTAL;

ABDOMINAL PAIN; ADULT; AMENORRHEA; ARTICLE; BREAST CANCER; CHLAMYDIASIS; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; ENDOMETRIUM BIOPSY; FEMALE; HEADACHE; HISTOLOGY; HUMAN; HYPERPLASIA; MAJOR CLINICAL STUDY; MENORRHAGIA; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINOPHARYNGITIS; THYROID CYST; TREATMENT DURATION; UTERUS BLEEDING; UTERUS MYOMA;

LONG-TERM TREATMENT; ULIPRISTAL ACETATE; UTERINE FIBROID;

ADMINISTRATION, ORAL; ADULT; AMENORRHEA; ANTINEOPLASTIC AGENTS, HORMONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; ENDOMETRIUM; EUROPE; FEMALE; HUMANS; LEIOMYOMA; MENORRHAGIA; MIDDLE AGED; NORETHINDRONE; NORPREGNADIENES; PELVIC PAIN; QUALITY OF LIFE; TIME FACTORS; TREATMENT OUTCOME; TUMOR BURDEN; UTERINE NEOPLASMS;

EID: 84899580132     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2014.02.008     Document Type: Article

References (44)

1. M. Mehine, E. Kaasinen, N. Mäkinen, R. Katainen, K. Kämpjärvi, and E. Pitkänen et al. Characterization of uterine leiomyomas by whole-genome sequencing N Engl J Med 369 2013 43 53
2. E.E. Wallach, and N.F. Vlahos Uterine myomas: an overview of development, clinical features, and management Obstet Gynecol 104 2004 393 406 (Pubitemid 40458890)
3. E.A. Stewart Uterine fibroids Lancet 357 2001 293 298 (Pubitemid 32120866)
4. J. Donnez, and P. Jadoul What are the implications of myomas on fertility? A need for a debate? Hum Reprod 17 2002 1424 1430 (Pubitemid 34661784)
5. E.A. Stewart Uterine fibroids and evidence-based medicine - not an oxymoron N Engl J Med 366 2012 471 473
6. J. Donnez, B. Schrurs, S. Gillerot, J. Sandow, and F. Clerckx Treatment of uterine fibroids with implants of gonadotropin-releasing hormone agonist: assessment by hysterography Fertil Steril 51 1989 947 950 (Pubitemid 19156895)
7. A. Lethaby, and B. Vollenhoven Fibroids (uterine myomatosis, leiomyomas) Clin Evid (Online) 2011 2011 0814
8. L.B. Zapata, M.K. Whiteman, N.K. Tepper, D.J. Jamieson, P.A. Marchbanks, and K.M. Curtis Intrauterine device use among women with uterine fibroids: a systematic review Contraception 82 2010 41 55
9. G.B. Melis, B. Piras, M.F. Marotto, M.M. Orrù, G. Maricosu, and M. Pilloni et al. Pharmacokinetic evaluation of ulipristal acetate for uterine leiomyoma treatment Expert Opin Drug Metab Toxicol 8 2012 901 908
10. E.E. Gainer, and A. Ulmann Pharmacologic properties of CDB(VA)-2914 Steroids 68 2003 1005 1011 (Pubitemid 37532425)
11. P. Horak, M. Mara, P. Dundr, K. Kubinova, D. Kuzel, and R. Hudecek et al. Effect of a selective progesterone receptor modulator on induction of apoptosis in uterine fibroids in vivo Int J Endocrinol 2012 2012 436174
12. O. Pohl, I. Osterloh, and J.P. Gotteland Ulipristal acetate - safety and pharmacokinetics following multiple doses of 10-50 mg per day J Clin Pharm Ther 38 2013 314 320
13. J. Donnez, T.F. Tatarchuk, P. Bouchard, L. Puscasiu, N.F. Zakharenko, and T. Ivanova et al. Ulipristal acetate versus placebo for fibroid treatment before surgery N Engl J Med 366 2012 409 420
14. J. Donnez, J. Tomaszewski, F. Vazquez, P. Bouchard, B. Lemieszczuk, and F. Baro et al. Ulipristal acetate versus leuprolide acetate for uterine fibroids N Engl J Med 366 2012 421 432
15. G.L. Mutter, C. Bergeron, L. Deligdisch, A. Ferenczy, M. Glant, and M. Merino et al. The spectrum of endometrial pathology induced by progesterone receptor modulators Mod Pathol 21 2008 591 598 (Pubitemid 351589653)
16. J. Fiscella, T. Bonfiglio, P. Winters, S.H. Eisinger, and K. Fiscella Distinguishing features of endometrial pathology after exposure to the progesterone receptor modulator mifepristone Hum Pathol 42 2011 947 953
17. O.B. Ioffe, R.J. Zaino, and G.L. Mutter Endometrial changes from short-term therapy with CDB-4124, a selective progesterone receptor modulator Mod Pathol 22 2009 450 459
18. A.R. Williams, C. Bergeron, D.H. Barlow, and A. Ferenczy Endometrial morphology after treatment of uterine fibroids with the selective progesterone receptor modulator, ulipristal acetate Int J Gynecol Pathol 31 2012 556 569
19. J.M. Higham, P.M. O'Brien, and R.W. Shaw Assessment of menstrual blood loss using a pictorial chart Br J Obstet Gynaecol 97 1990 734 739 (Pubitemid 20263124)
20. R. Melzack The short-form McGill Pain Questionnaire Pain 30 1987 191 197 (Pubitemid 18029372)
21. P. Dolan Modeling valuations for EuroQol health states Med Care 35 1997 1095 1108 (Pubitemid 127453463)
22. J.B. Spies, K. Coyne, G.N. Guaou, D. Boyle, K. Skyrnarz-Murphy, and S.M. Gonzalves The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata Obstet Gynecol 99 2002 290 300 (Pubitemid 34114003)
23. K. Fiscella, S.H. Eisinger, S. Meldrum, C. Feng, S.G. Fisher, and D.S. Guzick Effect of mifepristone for symptomatic leiomyomata on quality of life and uterine size: a randomized controlled trial Obstet Gynecol 108 2006 1381 1387 (Pubitemid 44901011)
24. J.B. Spies, L.D. Bradley, R. Guido, G.L. Maxwell, B.A. Levine, and K. Coyne Outcomes from leiomyoma therapies: comparison with normal controls Obstet Gynecol 116 2010 641 652
25. T. Takeda, K. Osuga, A. Miyake, A. Wakabayashi, K. Morishige, and T. Kimura Elevated level of plasma vascular endothelial growth factor after gonadotropin-releasing hormone agonist treatment for leiomyomata Gynecol Endocrinol 24 2008 724 726
26. H.S. Kim, J.H. Baik, L.D. Pham, and M.A. Jacobs MR-guided high-intensity focused ultrasound treatment for symptomatic uterine leiomyomata: long-term outcomes Acad Radiol 18 2011 970 976
27. J.J. Kim, and E.C. Sefton The role of progesterone signaling in the pathogenesis of uterine leiomyoma Mol Cell Endocrinol 358 2012 223 231
28. A.R. Scialli, and K.J. Jestila Sustained benefits of leuprolide acetate with or without subsequent medroxyprogesterone acetate in the nonsurgical management of leiomyomata uteri Fertil Steril 64 1995 313 320
29. E.D. Levens, C. Potlog-Nahari, A.Y. Armstrong, R. Wesley, A. Premkumar, and D.L. Blithe et al. CDB-2914 for uterine leiomyomata treatment: a randomized controlled trial Obstet Gynecol 111 2008 1129 1136 (Pubitemid 351620347)
30. L.K. Nieman, W. Blocker, T. Nansel, S. Mahoney, J. Reynolds, and D. Blithe et al. Efficacy and tolerability of CDB-2914 treatment for symptomatic uterine fibroids: a randomized, double-blind, placebo-controlled, phase IIb study Fertil Steril 95 2011 767 772
31. J.M. Higham, P.M. O'Brien, and R.W. Shaw Assessment of menstrual blood loss using a pictorial chart Br J Obstet Gynaecol 97 1990 734 739 (Pubitemid 20263124)
32. C.A. Janssen, P.C. Scholten, and A.P. Heintz A simple visual assessment technique to discriminate between menorrhagia and normal menstrual blood loss Obstet Gynecol 85 1995 977 982
33. C.S. Philipp, A. Faiz, J.A. Heit, P.A. Kouides, A. Lukes, and S.F. Stein et al. Evaluation of a screening tool for bleeding disorders in a US multisite cohort of women with menorrhagia Am J Obstet Gynecol 204 2011 209.e1 209.e7
34. M.S. Zakherah, G.H. Sayed, S.A. El-Nashar, and M.M. Shaaban Pictorial blood loss assessment chart in the evaluation of heavy menstrual bleeding: diagnostic accuracy compared to alkaline hematin Gynecol Obstet Invest 71 2011 281 284
35. R.A. Kadir, C.A. Lee, C.A. Sabin, D. Pollard, and D.L. Economides DDAVP nasal spray for treatment of menorrhagia in women with inherited bleeding disorders: a randomized placebo-controlled crossover study Haemophilia 8 2002 787 793 (Pubitemid 35446632)
36. P.A. Kouides, V.R. Byams, C.S. Philipp, S.F. Stein, J.A. Heit, and A.S. Lukes et al. Multisite management study of menorrhagia with abnormal laboratory haemostasis: a prospective crossover study of intranasal desmopressin and oral tranexamic acid Br J Haematol 145 2009 212 220
37. A. Kriplani, V. Kulshrestha, and N. Agarwal Efficacy and safety of ormeloxifene in management of menorrhagia: a pilot study J Obstet Gynaecol Res 35 2009 746 752
38. P.C. Reid, and S. Virtanen-Kari Randomised comparative trial of the levonorgestrel intrauterine system and mefenamic acid for the treatment of idiopathic menorrhagia: a multiple analysis using total menstrual fluid loss, menstrual blood loss and pictorial blood loss assessment charts Br J Obstet Gynaecol 112 2005 1121 1125 (Pubitemid 41632669)
39. R.A. Busfield, C.M. Farquhar, M.C. Sowter, A. Lethaby, M. Sprecher, and Y. Yu et al. A randomized trial comparing the levonorgestrel intrauterine system and thermal balloon ablation for heavy menstrual bleeding Obstet Gynecol Surv 61 2006 444 445 (Pubitemid 43970446)
40. R. Melzack The Short-Form McGill Pain Questionnaire Pain 30 1987 191 197 (Pubitemid 18029372)
41. J.B. Spies, K. Coyne, G.N. Guaou, D. Boyle, K. Skyrnarz-Murphy, and S.M. Gonzalves The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata Obstet Gynecol 99 2002 290 300 (Pubitemid 34114003)
42. A.R. Williams, C. Bergeron, D.H. Barlow, and A. Ferenczy Endometrial morphology after treatment of uterine fibroids with the selective progesterone receptor modulator, ulipristal acetate Int J Gynecol Pathol 31 2012 556 569
43. G.L. Mutter, C. Bergeron, L. Deligdisch, A. Ferenczy, M. Glant, and M. Merino et al. The spectrum of endometrial pathology induced by progesterone receptor modulators Mod Pathol 21 2008 591 598 (Pubitemid 351589653)
44. D. Brown, S. Day, R. Hemmings, and D. Wright Assessing the impact of ICH E9 Pharm Stat 7 2008 77 87 (Pubitemid 351943636)